Moreover, in the study by Quast et al., which used esophageal pH and manometry to evaluate the frequency and severity of reflux episodes in patients before and after GLP-1 RA treatment, all participants took GLP-1 RAs for type 2 diabetes. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.